QbD Unlocked: Smarter Tech Transfer for Biologics
A data-driven approach to process characterization and validation for scalable biologics manufacturing.
This white paper examines how a quality by design approach is applied to technology transfer and process characterization for biologic drugs, including a monoclonal antibody case study.
This white paper examines how a quality by design approach is applied to technology transfer and process characterization for biologic drugs, including a monoclonal antibody case study.
Applying QbD to Tech Transfer
Defining critical quality attributes and process parameters up front makes transfer more predictable.
Process Characterization
Risk-based studies establish the design space and support a robust control strategy.
Monoclonal Antibody Case Study
A worked example shows how data-driven decisions shorten transfer and strengthen validation.
Download This White Paper
Biotechnology Media Insights
Continue to Biotechnology Media Insights to access this white paper.